Skip to main content

The latest news &
insights from ArteraAI

View company news, research articles, publications, and industry thought leadership currently making headlines in the cancer treatment space.

Right Image
Show All
Press & Media
Publications & Presentations
Upcoming & Past Events
Videos
Insights
Upcoming & Past Events

2023 ASCO Oral Presentation by Dr. Andrew Armstrong

Learn about the development and validation of an AI-derived digital pathology-based biomarker to predict benefit of long-term [...]

Publications & Presentations

Mack Roach, MD, FASTRO, FASCO

Dr. Roach discusses how the performance of the multimodal artificial intelligence (MMAI)-derived prognostic biomarker is comp [...]

Publications & Presentations

Daniel Spratt, MD

Dr. Spratt discusses how an MMAI-derived predictive biomarker is able to discriminate between patients with intermediate-risk [...]

Publications & Presentations

Osama Mohamad, MD

Dr. Mohamad discusses the development and validation of a multimodal artificial intelligence (MMAI)-derived prognostic biomar [...]

Press & Media

Florida medical tech company launches novel AI test for...

ArteraAI’s ‘first-ever predictive test’ helps doctors choose personalized treatment for patients Fox News Article

Press & Media

Can Artificial Intelligence Help Diagnose Prostate Cancer?

AI may be a medical game-changer, with the power of machine learning advancing the efficacy of prostate cancer biopsies and m [...]

Press & Media

Andre Esteva of ArteraAI: 5 Things I Wish Someone...

Medium’s Doug Noll spoke with the CEO of ArteraAI, Andre Esteva, to discuss his path from Stanford University to founding fou [...]

Press & Media

ArteraAI and ACS form collaboration to use AI for...

ArteraAI and the American Cancer Society formed a collaboration focused on the development of AI-driven cancer therapy person [...]

Press & Media

ArteraAI and American Cancer Society Announce New Relationship

ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, and the American [...]

Load More